N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
Adcytherix SAS
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shanghai Juncell Therapeutics
Guangzhou FineImmune Biotechnology Co., LTD.
Guangzhou FineImmune Biotechnology Co., LTD.
Capital Medical University
Capital Medical University
Eastern Cooperative Oncology Group
Aminex Therapeutics, Inc.
OHSU Knight Cancer Institute
Virginia Commonwealth University
Indiana University
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Rochester
NYU Langone Health